These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3997298)

  • 1. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
    Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.
    Traeger A; Stein G; Sperschneider H; Keil E
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Furosemide effects in patients with chronic renal insufficiency].
    Sperschneider H; Stein G; Traeger A; Keil E
    Z Gesamte Inn Med; 1984 Jun; 39(11):261-5. PubMed ID: 6475170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furosemide kinetics and dynamics in patients with cirrhosis.
    Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
    Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
    BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis.
    Sanchis Closa A; Lambert C; du Souich P
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):461-6. PubMed ID: 8225696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics and pharmacodynamics of furosemide in liver cirrhosis].
    Tesar V; Kotal P; Petrtýl J; Bukovská J; Kozáková M; Brodanová M; Horký K; Kordac V
    Cas Lek Cesk; 1990 May; 129(21):657-64. PubMed ID: 2369756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
    Dreux C; Passa P; Halter D
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):289-96. PubMed ID: 552592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
    Knauf H; Mutschler E
    Arzneimittelforschung; 2005; 55(1):1-14. PubMed ID: 15727159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of famotidine after intravenous administration in liver disease.
    Ohnishi K
    Am J Gastroenterol; 1991 Jan; 86(1):41-5. PubMed ID: 1986553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
    Farghali H; Al Zuhair H; Al Windawi S; Al Hamdi A; Fariduddin M
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
    Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
    Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of diuretics after pretreatment with reserpine and 6-OH-dopamine (author's transl)].
    Hörl WH; Hennemann HM; Heidland A
    Arzneimittelforschung; 1976 Apr; 26(4):539-43. PubMed ID: 989009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
    Mansurov KhKh; Dustov AD
    Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the diuretic and natriuretic effect of furosemide by the calcium antagonist nifedipine.
    Piryova B; Girchev R
    Acta Physiol Pharmacol Bulg; 1989; 15(1):13-8. PubMed ID: 2773646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.